Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

N

NVCT

Nuvectis Pharma Inc

20.19

Aug 04 • 9:59 AM ET -1.41 (-6.53%)

Healthcare Biotechnology USA Small NASD

Peers: ALXO FHTX BCYC CGEN FATE CDXS IKT NBP NERV AKTX

| Held by: VTI IWM VXF IWO FESM VTWO IWC ITOT VTWG GSSC

Scroll to Statements

Index	RUT
Market Cap	636.50M
Enterprise Value	611.37M
Income	-29.59M
Sales	0.00M
Book/sh	0.54
Cash/sh	0.80
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	13
IPO	Feb 04, 2022

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	37.66
P/C	25.33
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	2.27
Current Ratio	2.27
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-1.27
EPS next Y	-1.01
EPS next Q	-0.26
EPS this Y	23.64%
EPS next Y	-0.60%
EPS next 5Y	-0.13%
EPS past 3/5Y	4.25% -340.28%
Sales past 3/5Y	- -
EPS Y/Y TTM	-16.88%
Sales Y/Y TTM	-
EPS Q/Q	3.37%
Sales Q/Q	-
Earnings	May 05 BMO
EPS/Sales Surpr.	17.20% -

Insider Own	42.78%
Insider Trans	0.47%
Inst Own	14.93%
Inst Trans	2.88%
ROA	-106.54%
ROE	-168.24%
ROIC	-208.08%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	2.98%
SMA50	21.75%
SMA200	98.22%
Trades

Shs Outstand	26.53M
Shs Float	18.04M
Short Float	8.38%
Short Ratio	5.11
Short Interest	1.51M
52W High	29.27 -31.03%
52W Low	5.55 263.78%
Volatility	7.53% 6.66%
ATR (14)	1.77
RSI (14)	53.73
Beta	-0.26
Rel Volume	6.93
Avg Volume	296.02K
Volume	247,617

Perf Week	1.87%
Perf Month	2.85%
Perf Quarter	127.11%
Perf Half Y	141.51%
Perf YTD	167.42%
Perf Year	176.95%
Perf 3Y	39.24%
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	31.80
Prev Close	21.60
Price	20.19
Change	-6.53%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)